S. 3921 (111th): Ethical Pathway Act of 2010


Sep 29, 2010
111th Congress, 2009–2010

Died in a previous Congress

This bill was introduced on September 29, 2010, in a previous session of Congress, but was not enacted.


Bernard “Bernie” Sanders

Senator from Vermont



Read Text »
Last Updated: Sep 29, 2010
Length: 10 pages

About the bill

Full Title

A bill to ensure that rules for the approval of pharmaceutical and biological products do not require violations of medical ethics in the testing of products in humans and vertebrate animals.

Summary (CRS)

9/29/2010--Introduced.Ethical Pathway Act of 2010 - Directs the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA), to establish a mechanism by which ... Read more >

The bill’s title was written by its sponsor.


Sep 29, 2010

This is the first step in the legislative process.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 3921”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 3506 (112th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: Aug 2, 2012

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: